BusinessTempus and Cleveland Clinic Collaborate on Personalized Medicine InitiativeBy Nasdaq OMXSep 14, 2017, 2:30 PM UTC
BusinessTempus and University of California Davis Comprehensive Cancer Center Announce Personalized Medicine Partnership for Cancer PatientsBy Nasdaq OMXAug 31, 2017, 2:00 PM UTC
BusinessTempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium for Phase II Clinical TrialBy Nasdaq OMXAug 17, 2017, 1:00 PM UTC
BusinessARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXAug 3, 2017, 8:15 PM UTC
BusinessTempus Selected by University of Virginia As Partner for Large Granular Lymphocyte Leukemia Research ProjectBy Nasdaq OMXAug 3, 2017, 2:00 PM UTC
BusinessNovogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel PlatformBy Nasdaq OMXJul 18, 2017, 12:01 PM UTC
BusinessTempus and University of Chicago Medicine Collaborate on Pancreatic Cancer Research ProjectBy Nasdaq OMXJun 22, 2017, 2:30 PM UTC
BusinessARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017By Nasdaq OMXJun 20, 2017, 12:30 PM UTC
